Nektar Therapeutics
NKTR
$1.32
Share price
0.00%
Change (1 day)
76.00%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Cash on Hand
Cash on Hand as of December 2023 : $0.30 B
According to Nektar Therapeutics
's latest financial reports the company has $0.30 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nektar Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.30 B | -39.88% |
| 2022-12-31 | $0.50 B | -31.2% |
| 2021-12-31 | $0.73 B | -30.88% |
| 2020-12-31 | $1.06 B | -19.85% |
| 2019-12-31 | $1.32 B | -0.79% |
| 2018-12-31 | $1.33 B | 350.93% |
| 2017-12-31 | $0.29 B | -23.89% |
| 2016-12-31 | $0.38 B | 25.95% |
| 2015-12-31 | $0.30 B | 29.9% |
| 2014-12-31 | $0.23 B | 0.34% |
| 2013-12-31 | $0.23 B | -14.49% |
| 2012-12-31 | $0.27 B | 14.94% |
| 2011-12-31 | $0.24 B | -23.66% |
| 2010-12-31 | $0.31 B | -20.26% |
| 2009-12-31 | $0.39 B | 4.54% |
| 2008-12-31 | $0.37 B | -21.43% |
| 2007-12-31 | $0.48 B | 5.17% |
| 2006-12-31 | $0.45 B | -3.69% |
| 2005-12-31 | $0.47 B | 13.72% |
| 2004-12-31 | $0.41 B | 46.43% |
| 2003-12-31 | $0.28 B | -2.72% |
| 2002-12-31 | $0.29 B | -14.63% |
| 2001-12-31 | $0.34 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 7,451.31% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 4,079.62% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 3,504.55% | 🇺🇸 USA |
 Baxter BAX | $3.19 B | 951.99% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 2,236.17% | 🇺🇸 USA |
 AstraZeneca AZN | $8.02 B | 2,541.82% | 🇬🇧 UK |
 Richardson Electronics RELL | $18.88 M | -93.78% | 🇺🇸 USA |
 Alkermes ALKS | $0.77 B | 154.76% | 🇮🇪 Ireland |